![Christian Brechot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Brechot
Director/Board Member at
Fondation Mérieux
Profile
Christian Bréchot (born 23 July 1952) is a French physician and scientist who has been serving as president of the Global Virus Network (GVN) since 2017. He previously served as president of the Institut Pasteur from 2013 until 2017 and as chief executive officer of the French National Institute for Health and Medical Research (INSERM) from 2001 to 2007.
Christian Brechot active positions
| Companies | Position | Start |
|---|---|---|
Fondation Mérieux
 Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Board Member | - |
Fondation Ophtalmologique Adolphe de Rothschild
 Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Operates a hospital for the treatment and diagnosis of opthalmic and neurologic diseases | Director/Board Member | - |
European Personalised Medicine Association | Director/Board Member | - |
Institut Pasteur Korea
 Institut Pasteur Korea BiotechnologyHealth Technology Provides research and development for the treatment of infectious and chronic diseases | Director/Board Member | - |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Director/Board Member | - |
Rarecells Diagnostics SAS
 Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Director/Board Member | - |
Former positions of Christian Brechot
| Companies | Position | End |
|---|---|---|
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | President | 2017-10-12 |
| BIOMÉRIEUX | Director/Board Member | 2011-12-31 |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Corporate Officer/Principal | 2006-12-31 |
| ░░░░░░░░░░ ░░ | ░░░░░░░ | - |
| ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Christian Brechot
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
bioMérieux SA
 bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
ScreenCell SA
 ScreenCell SA Miscellaneous Commercial ServicesCommercial Services Offers clinically confirmed solutions for the isolation of rare cells in the blood and other fluids | Commercial Services |
Fondation Mérieux
Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Compagnie Merieux Alliance SAS
 Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Functions as an investment fund | Miscellaneous |
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Provides drug and research development services | Health Technology |
Institut Pasteur Korea
Institut Pasteur Korea BiotechnologyHealth Technology Provides research and development for the treatment of infectious and chronic diseases | Health Technology |
Hopital Necker-Enfants Malades | |
Fondation Ophtalmologique Adolphe de Rothschild
Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Operates a hospital for the treatment and diagnosis of opthalmic and neurologic diseases | Health Services |
European Personalised Medicine Association | |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Technology Services |
- Stock Market
- Insiders
- Christian Brechot
